Stock Events

Stock Events

NRX Pharmaceuticals 

€1.37
85
-€0.13-8.67% Friday 08:55

Statistics

Day High
1.37
Day Low
1.37
52W High
3.32
52W Low
1.37
Volume
-
Avg. Volume
-
Mkt Cap
38.49M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

26MarExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
-0.84
-0.56
-0.28
0.01
Expected EPS
0.00651574
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-47.92MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow B1Q.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical company that competes with NRX Pharmaceuticals in the development and marketing of medications for various therapeutic areas, including mental health.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its pharmaceutical segment Janssen, competes in developing treatments for disorders that NRX Pharmaceuticals targets, including mental health and other areas.
Merck
MRK
Mkt Cap214.76B
Merck & Co. is involved in the research, development, and marketing of drugs that address conditions similar to those targeted by NRX Pharmaceuticals, making them a direct competitor.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly and Company competes with NRX Pharmaceuticals in the psychiatric and neurological drug market, particularly in areas like depression and bipolar disorder.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie competes in the neuroscience and mental health drug market, areas that are of interest to NRX Pharmaceuticals, with a strong portfolio in psychiatric drugs.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb offers a range of products that compete in the therapeutic areas targeted by NRX Pharmaceuticals, including mental health treatments.
Novartis
NVS
Mkt Cap237.61B
Novartis AG competes with NRX Pharmaceuticals through its extensive research and development in therapies for neurological and mental health conditions.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline competes in the pharmaceutical market for mental health medications, a key area of focus for NRX Pharmaceuticals.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries is a global competitor in generic and specialty medicines, including those for neurological and psychiatric conditions that NRX Pharmaceuticals also targets.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is involved in the development of therapies for various diseases, including those in the neurological and psychiatric domain, making them a competitor to NRX Pharmaceuticals.

About

NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.
Show more...
CEO
Dr. Jonathan C. Javitt M.D., M.P.H.
Country
US
ISIN
US6294442099
WKN
000A4091K

Listings

XNAS
US
NRXPW
F
DE
B1Q.F
XNAS
US
NRXP
BOATS
BOATS
NRXP.BOATS

0 Comments

Share your thoughts

FAQ

What is NRX Pharmaceuticals stock price today?▼
The current price of B1Q.F is €1.37 EUR — it has decreased by -8.67% in the past 24 hours. Watch NRX Pharmaceuticals stock price performance more closely on the chart.
What is NRX Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange NRX Pharmaceuticals stocks are traded under the ticker B1Q.F.
Is NRX Pharmaceuticals stock price growing?▼
B1Q.F stock has fallen by -19.88% compared to the previous week, the month change is a -30.1% fall, over the last year NRX Pharmaceuticals has showed a -54.93% decrease.
What is NRX Pharmaceuticals market cap?▼
Today NRX Pharmaceuticals has the market capitalization of 38.49M
When is the next NRX Pharmaceuticals earnings date?▼
NRX Pharmaceuticals is going to release the next earnings report on March 26, 2026.
What were NRX Pharmaceuticals earnings last quarter?▼
B1Q.F earnings for the last quarter are -0.23 EUR per share, whereas the estimation was -0.02 EUR resulting in a -1,239.95% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is NRX Pharmaceuticals revenue for the last year?▼
NRX Pharmaceuticals revenue for the last year amounts to 0 EUR.
What is NRX Pharmaceuticals net income for the last year?▼
B1Q.F net income for the last year is -47.92M EUR.
In which sector is NRX Pharmaceuticals located?▼
NRX Pharmaceuticals operates in the Health Care sector.
When did NRX Pharmaceuticals complete a stock split?▼
The last stock split for NRX Pharmaceuticals was on April 02, 2024 with a ratio of 1:10.
Where is NRX Pharmaceuticals headquartered?▼
NRX Pharmaceuticals is headquartered in Wilmington, US.